Genflow Biosciences PLC (GENF)

Currency in GBP
0.68
+0.05(+7.94%)
Real-time Data·
GENF Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
GENF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.600.70
52 wk Range
0.552.40
Key Statistics
Bid/Ask
0.65 / 0.70
Prev. Close
0.63
Open
0.63
Day's Range
0.6-0.7
52 wk Range
0.55-2.4
Volume
325.52K
Average Volume (3m)
8.02M
1-Year Change
-67.69%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GENF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Genflow Biosciences PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Genflow Biosciences PLC Company Profile

Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with an increase in health span. Its lead drug candidate is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-1003, a topical delivery of SIRT6 to the skin; GF-1004, a non-human pipeline anti-aging for veterinary use; GF-1005, a mitochondrial dysfunction for muscle health and combat sarcopenia; and GF-1006, an ophthalmology mRNA cent SIRT6 for the treatment of cornea pathologies and glaucoma. It has collaborative research agreements with Revatis SA and EXO Biologics for therapy medicinal products. Genflow Biosciences plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

Compare GENF to Peers and Sector

Metrics to compare
GENF
Peers
Sector
Relationship
P/E Ratio
−1.8x−6.4x−0.5x
PEG Ratio
−0.07−0.040.00
Price/Book
−7.1x4.8x2.6x
Price / LTM Sales
-13.4x3.3x
Upside (Analyst Target)
-78.5%42.8%
Fair Value Upside
Unlock−14.5%6.5%Unlock

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-792,110.00 / --
EPS Revisions
Last 90 days

GENF Income Statement

People Also Watch

5.00
HAMA
+2.04%
1.69
TIRU
+5.00%
0.0782
NFXN
-2.25%
0.01
MIRI
0.00%
0.39
ALRT
+5.41%

FAQ

What Stock Exchange Does Genflow Biosciences Trade On?

Genflow Biosciences is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Genflow Biosciences?

The stock symbol for Genflow Biosciences is "GENF."

What Is the Genflow Biosciences Market Cap?

As of today, Genflow Biosciences market cap is 2.83M.

What Is Genflow Biosciences's Earnings Per Share (TTM)?

The Genflow Biosciences EPS (TTM) is -0.00.

From a Technical Analysis Perspective, Is GENF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Genflow Biosciences Stock Split?

Genflow Biosciences has split 0 times.

How Many Employees Does Genflow Biosciences Have?

Genflow Biosciences has 5 employees.

What is the current trading status of Genflow Biosciences (GENF)?

As of 06 Aug 2025, Genflow Biosciences (GENF) is trading at a price of 0.68, with a previous close of 0.63. The stock has fluctuated within a day range of 0.60 to 0.70, while its 52-week range spans from 0.55 to 2.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.